Context Therapeutics (CNTX) announced the appointment of Andy Pasternak as Chairman of its Board of Directors, succeeding Richard Berman, who stepped down from the Board effective January 12, 2025. Most recently, Pasternak served as Executive Vice President, Chief Strategy Officer at Horizon Therapeutics.